Skip to menu Skip to content Skip to footer

Enabling Immune Checkpoint Inhibitor Treatment for Triple Negative Breast Cancer (2026-2030)

Experts

Professor Michael Yu

Professorial Research Fellow & SGL
Australian Institute for Bioengineering and Nanotechnology
Michael Yu
Michael Yu